26 May 2026
17:55 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren : adoption de tous les points à l'ordre du jour de l'assemblée générale, y compris un dividende brut de 4,60 euros par action.
|
50101015 Engineering and Contracting Services |
Income |
26 May 2026
17:55 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren: alle agendapunten van de JAV goedgekeurd, inclusief brutodividend van 4,60 euro per aandeel
|
50101015 Engineering and Contracting Services |
Income |
26 May 2026
17:55 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren: all items on the agenda of the ASM approved, incl. gross dividend of €4.60 per share
|
50101015 Engineering and Contracting Services |
Income |
21 May 2026
07:00 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren (Trading Update Q1 2026): Sterke start van het jaar voor de kernparticipaties. Bevestiging van prognose.
|
50101015 Engineering and Contracting Services |
Income |
21 May 2026
07:00 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren (Trading Update Q1 2026): Début d'année solide pour les participations clés. Confirmation des prévisions.
|
50101015 Engineering and Contracting Services |
Income |
21 May 2026
07:00 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren (Trading Update Q1 2026): Strong start to the year of core participations. Confirmation of guidance.
|
50101015 Engineering and Contracting Services |
Income |
27 Feb 2026
07:00 CET |
ACKERMANS V.HAAREN |
Ackermans & van Haaren sluit een succesvol jaar af met een nettowinst van 593 miljoen euro (+29%)
|
50101015 Engineering and Contracting Services |
Income |
27 Feb 2026
07:00 CET |
ACKERMANS V.HAAREN |
Ackermans & van Haaren clôture un excellent exercice 2025 avec un bénéfice net de 593 millions d'euros (+29%)
|
50101015 Engineering and Contracting Services |
Income |
27 Feb 2026
07:00 CET |
ACKERMANS V.HAAREN |
Ackermans & van Haaren ends a successful year 2025 with a net profit of 593 million euros (+29%)
|
50101015 Engineering and Contracting Services |
Income |
21 Nov 2025
07:00 CET |
ACKERMANS V.HAAREN |
Ackermans & van Haaren trading update 3T2025: excellents résultats des participations principales, perspectives 2025 confirmées
|
30202000 Diversified Financial Services |
Income |
21 Nov 2025
07:00 CET |
ACKERMANS V.HAAREN |
Ackermans & van Haaren Trading Update 3Q2025: Excellent results of core participations, FY2025 Outlook confirmed
|
30202000 Diversified Financial Services |
Income |
21 Nov 2025
07:00 CET |
ACKERMANS V.HAAREN |
Ackermans & van Haaren Trading Update 3Q25: uitstekende resultaten van de kernparticipaties, FY2025 vooruitzichten bevestigd
|
30202000 Diversified Financial Services |
Income |
25 Sep 2025
07:00 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren investeert 22 miljoen euro in VKC Nuts
|
30202000 Diversified Financial Services |
Income |
25 Sep 2025
07:00 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren investit 22 millions d'euros dans VKC Nuts
|
30202000 Diversified Financial Services |
Income |
25 Sep 2025
07:00 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren invests 22 million euros in VKC Nuts
|
30202000 Diversified Financial Services |
Income |
04 Sep 2025
07:15 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren ondersteunt de serie B-financieringsronde van 55 miljoen euro van MRM Health
|
30202000 Diversified Financial Services |
Income |
04 Sep 2025
07:15 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren soutient le tour de financement de série B de 55 millions d’euros de MRM Health
|
30202000 Diversified Financial Services |
Income |
04 Sep 2025
07:15 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren supports MRM Health’s Series B financing round of 55 million euros
|
30202000 Diversified Financial Services |
Income |
02 Sep 2025
07:00 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren investeert 20 miljoen US dollar in het tweede fonds van Venturi Partners
|
30202000 Diversified Financial Services |
Income |
02 Sep 2025
07:00 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren s’engage à hauteur de 20 millions de dollars dans le deuxième fonds de Venturi Partners
|
30202000 Diversified Financial Services |
Income |
02 Sep 2025
07:00 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren commits 20 million US dollars to the second fund of Venturi Partners
|
30202000 Diversified Financial Services |
Income |
29 Aug 2025
07:00 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren: Halfjaarresultaten 2025
|
30202000 Diversified Financial Services |
Income |
29 Aug 2025
07:00 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren: First-Half 2025 Results
|
30202000 Diversified Financial Services |
Income |
29 Aug 2025
07:00 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren : Résultats semestriels 2025
|
30202000 Diversified Financial Services |
Income |
26 May 2025
17:45 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren: the General Shareholders' Meeting approves all proposed resolutions by a vast majority
|
30202000 Diversified Financial Services |
Income |
26 May 2025
17:45 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren : l'Assemblée Générale a approuvé toutes les résolutions proposées à une large majorité
|
30202000 Diversified Financial Services |
Income |
26 May 2025
17:45 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren: de Algemene Aandeelhoudersvergadering keurt alle voorstellen tot besluit goed met ruime meerderheid
|
30202000 Diversified Financial Services |
Income |
22 May 2025
07:00 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren (Trading Update Q1 2025): AvH meldt solide start van het jaar en bevestigt jaarprognose
|
30202000 Diversified Financial Services |
Income |
22 May 2025
07:00 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren (Trading Update T1 2025): début d'année solide et confirmation des prévisions
|
30202000 Diversified Financial Services |
Income |
22 May 2025
07:00 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren (Trading Update Q1 2025): AvH reports solid start to the year and confirms guidance
|
30202000 Diversified Financial Services |
Income |
04 Apr 2025
17:42 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren: publication of a transparency notification
|
30202000 Diversified Financial Services |
Income |
04 Apr 2025
17:42 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren : publication relative à une notification de transparence
|
30202000 Diversified Financial Services |
Income |
04 Apr 2025
17:42 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren: openbaarmaking van een transparantiekennisgeving
|
30202000 Diversified Financial Services |
Income |
28 Feb 2025
07:00 CET |
ACKERMANS V.HAAREN |
Ackermans & van Haaren grows net profit by 15% in 2024 to 460 million euros.
|
30202000 Diversified Financial Services |
Income |
28 Feb 2025
07:00 CET |
ACKERMANS V.HAAREN |
Ackermans & van Haaren augmente son bénéfice net pour 2024 de 15% à 460 millions d'euros.
|
30202000 Diversified Financial Services |
Income |
28 Feb 2025
07:00 CET |
ACKERMANS V.HAAREN |
Ackermans & van Haaren realiseert 15% groei van nettowinst in 2024 tot 460 miljoen euro.
|
30202000 Diversified Financial Services |
Income |
22 Nov 2024
07:00 CET |
ACKERMANS V.HAAREN |
Ackermans & van Haaren Trading Update Q3 2024 - AvH is on track towards a net profit well above 400 million euros
|
30202000 Diversified Financial Services |
Income |
22 Nov 2024
07:00 CET |
ACKERMANS V.HAAREN |
Ackermans & van Haaren Trading Update T3 2024 - AvH en bonne voie de réaliser un bénéfice bien supérieur à 400 millions d’euros.
|
30202000 Diversified Financial Services |
Income |
22 Nov 2024
07:00 CET |
ACKERMANS V.HAAREN |
Ackermans & van Haaren Trading Update 3e kwartaal 2024 - AvH op koers voor nettowinst van ruim boven 400 miljoen euro
|
30202000 Diversified Financial Services |
Income |
21 Nov 2024
07:00 CET |
ACKERMANS V.HAAREN |
Ackermans & van Haaren and the Delen family confirm their long-term partnership with updated shareholder arrangements in respect of Delen Private Bank and Bank J. Van Breda & Co
|
30202000 Diversified Financial Services |
Income |
21 Nov 2024
07:00 CET |
ACKERMANS V.HAAREN |
Ackermans & van Haaren en de familie Delen bevestigen hun langetermijnpartnership met aangepaste aandeelhoudersregelingen met betrekking tot Delen Private Bank en Bank J. Van Breda & Co
|
30202000 Diversified Financial Services |
Income |
21 Nov 2024
07:00 CET |
ACKERMANS V.HAAREN |
Ackermans & van Haaren et la famille Delen confirment leur partenariat à long terme en actualisant les conventions d'actionnaires concernant Delen Private Bank et Bank J.Van Breda & Co
|
30202000 Diversified Financial Services |
Income |
14 Oct 2024
08:15 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren invests an additional 5 million euros in Biotalys
|
30202000 Diversified Financial Services |
Income |
14 Oct 2024
08:15 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren investeert bijkomend 5 miljoen euro in Biotalys
|
30202000 Diversified Financial Services |
Income |
14 Oct 2024
08:15 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren investit 5 millions d’euros supplémentaires dans Biotalys
|
30202000 Diversified Financial Services |
Income |
30 Aug 2024
07:00 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren : Des résultats exceptionnels dans les participations principales entraînent une forte augmentation du bénéfice net qui atteint € 200 millions (+17%)
|
30202000 Diversified Financial Services |
Income |
30 Aug 2024
07:00 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren: Uitstekende resultaten van kernparticipaties zorg voor sterke stijging van nettowinst van AvH in 1H2024 tot 200 miljoen euro (+17%)
|
30202000 Diversified Financial Services |
Income |
30 Aug 2024
07:00 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren: Outstanding results in core participations result in a strong increase of AvH's net profit for 1H2024 to EUR 200 million (+17%)
|
30202000 Diversified Financial Services |
Income |
26 Jul 2024
07:00 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren leidt Serie B-financierings-ronde van 60 miljoen euro voor Confo Therapeutics, een Belgische biofarmaceutische onderneming
|
30202000 Diversified Financial Services |
Income |
26 Jul 2024
07:00 CEST |
ACKERMANS V.HAAREN |
Ackermans & van Haaren mène une levée de fonds de série B de 60 millions d'euros pour Confo Therapeutics, une société biopharmaceutique belge
|
30202000 Diversified Financial Services |
Income |